CDC’s Ludicrous Makeover
BY HARVEY RISCH | BROWNSTONE INSTITUTE | AUGUST 18, 2022
CDC announced that the institutes have done an external/self-study and proposed a makeover “to restore public trust.” Dr. Walensky said that she “plans to remake the culture to help the agency move faster when it responds to a public health crisis. She also wants to make it easier for other parts of the government to work with the CDC, and wants to simplify and streamline the website to get rid of overlapping and contradictory public health guidance.”
The CDC’s announcement covers everything except the fundamental problem to which the director and the external reviewer are blind: industry subservience and epidemiologic incompetence.
CDC has published numbers of fatally flawed study reports over the last two years in MMWR, its captive journal. No amounts of “moving faster” will fix this problem. It took CDC two years to figure out that the vaccines are not an effective public health tool for reducing infection spread, something that I and numerous colleagues have been saying for more than a year.
CDC has still not recognized that for Covid, masks are useless, that distancing is useless, that general population testing is virtually useless for managing the population pandemic.
That the CDC has reviewed itself and only found trivialities and not the systematic problems that caused it to produce repeatedly failing policies shows that this review exercise was only window dressing. It was not a serious review.
The CDC needs a completely different independent external review to understand how it as a public health agency with MD and PhD epidemiologists could get so much science wrong for so long. The current makeover plans are ludicrous, will fool no one, and will not restore any of the large amount of public trust that has been lost by its poor performance over the last 2.5 years.
Harvey Risch is Professor of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine. Dr. Risch received his MD degree from the University of California San Diego and PhD from the University of Chicago. After serving as a postdoctoral fellow in epidemiology at the University of Washington, Dr. Risch was a faculty member in epidemiology and biostatistics at the University of Toronto before coming to Yale.
CDC says COVID vaccine status no longer relevant
By Mike Campbell | The Counter Signal | August 12, 2022
The CDC has dropped special quarantine recommendations for unvaccinated persons, finally admitting that natural immunity should be considered and that vaccines don’t stop infection.
“CDC’s COVID-19 prevention recommendations no longer differentiate based on a person’s vaccination status because breakthrough infections occur, though they are generally mild, and persons who have had COVID-19 but are not vaccinated have some degree of protection against severe illness from their previous infection,” their update reads.
The CDC removed the recommendation that unvaccinated persons quarantine after they’re exposed to the virus. They now recommend that individuals wear a mask for ten days post-exposure and get tested after five days.
The CDC further acknowledged that the Omicron variant of COVID poses a smaller risk of hospitalization and death than previous variants.
This announcement will likely pressure Canada’s health authorities (and Trudeau) to follow suit. Although numerous countries dropped their medical segregation policies long ago, Canada remains one of the last to do so.
Moreover, each consecutive variant appears to be weakening, with immunity (including natural immunity) being widespread. Although Canada has an abnormally high amount of mask and vaccine fanatics, the remaining medical segregation could soon be a thing of the past.
With that said, Canada’s health authorities have done nothing but warn of a return to restrictions and upcoming waves of COVID, telling Canadians that the pandemic is not over.
Additionally, the University of Toronto recently mandated that young health students living on residence get a 3rd vaccine.
CDC changes its messaging after I caught them out on their moneypox vaccine lies
By Meryl Nass, MD | August 1, 2022
Here are a few of the lies they have backed off:
1. As of July 28, CDC has ceased claiming the monkeypox vaccine(s) is 85% effective. It now admits it does not know its effectiveness.
2. CDC has stopped recommending the OFF LABEL use of moneypox vaccine post-exposure (even up to 14 days post-exposure was the recommendation earlier). They are now telling the truth, which is that the vaccine is only approved as a two dose series and it is licensed as effective only 2 weeks after the second dose, which is 6 weeks after starting the series. There is no data to support post-exposure prophylaxis, which is OFF LABEL use.
3. CDC finally admits that everyone getting vaccinated is a guinea pig in a big experiment.
4. However, CDC still OMITS what it knows about the dangers of these vaccines, information it provided to its advisory committee a mere month ago. ACAM 2000 vaccine causes myocarditis in one in every 175 recipients. And Jynneos seems to cause myocarditis too, as well as making HIV worse, according to the FDA review issued when the vaccines was licensed in 2019. We just don’t have the Jynneos statistics to say how often these problems occur, but in one study more than one in 6 subjects had elevation of cardiac enzymes, which requires some heart muscles cells to die.
Below is the new CDC messaging.
https://www.cdc.gov/poxvirus/monkeypox/considerations-for-monkeypox-vaccination.html
- Two vaccines may be used for the prevention of Monkeypox virus infection:
-
- JYNNEOS (also known as Imvamune or Imvanex), licensed (or approved) by the U.S. Food and Drug Administration (FDA) for the prevention of Monkeypox virus infection, and
- ACAM2000, licensed (or approved) by FDA for use against smallpox and made available for use against monkeypox under an Expanded Access Investigational New Drug application.
- In the United States, there is currently a limited supply of JYNNEOS, although more is expected in the coming weeks and months.
- There is a larger supply of ACAM2000, but this vaccine should not be used in people who have certain health conditions, such as a weakened immune system, skin conditions like eczema or other exfoliative skin conditions, or pregnancy.
- No data are available yet on the effectiveness of these vaccines in the current outbreak.
- The immune response takes 14 days after the second dose of JYNNEOS and 4 weeks after the ACAM2000 dose for maximal development. People who get vaccinated should continue to take steps to protect themselves from infection by avoiding close, skin-to-skin contact, including intimate contact, with someone who has monkeypox.
- To better understand the protective benefits of these vaccines in the current outbreak, CDC will collect data about adverse events and vaccine effectiveness, including whether the vaccine protects a person differently depending on how they were infected with Monkeypox virus.
New Evidence: Fauci Imposed a Vaccine Delay that Cost Trump the Election
By Toby Rogers | July 31, 2022
I. Fauci fires Trump
Think back to July 2020. Trump and Fauci were at war with each other. Key leaders within the Trump administration, including Peter Navarro, wanted to fire Fauci. There were riots in the streets as people protested the murder of George Floyd. And new evidence shows that behind the scenes, Fauci was working to torpedo Trump’s chances for re-election.
We already knew that Fauci, the FDA, CDC, and the pharmaceutical industry went to great lengths to block safe and effective treatments including hydroxychloroquine and ivermectin in order to prolong the pandemic and create the market for Covid-19 vaccines. But a new book reveals that Fauci also forced Moderna to delay their clinical trial by three weeks — which pushed the release of their preliminary results until after the presidential election.
This key piece of information comes from The Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World published last week by Harvard Business Review Press. The author, Peter Loftus, is a reporter for the Wall Street Journal and they published his essay about the book in their Review section on Saturday. What’s astonishing is that Loftus does not even realize the enormity of the story he just stumbled upon. Cultural capture and too many shots apparently prevent one from connecting the dots, so I will do it for him.
Most people already know the broad brush strokes of the Moderna story — they had never successfully brought a product to market before Operation Warp Speed. They were grifters — they took $25 million from the Defense Advanced Research Projects Agency (DARPA) in 2013 to develop mRNA products that never worked and another $125 million from the Biomedical Advanced Research and Development Authority (BARDA) in 2015 for a vaccine for Zika that also failed. But Fauci really liked these grifters and so when the pandemic began in 2020, BARDA directed $483 million to Moderna for Covid-19 vaccine development — and Moderna cut NIH in on the patents. That gave NIH and especially Fauci control over what came next.
The key paragraphs from Loftus’ WSJ essay are here:
Dr. Zaks [Chief Medical Officer for Moderna] had wanted to use a private contract research organization to run the whole trial, but NIAID officials wanted their clinical-trial network involved. Eventually, Dr. Zaks backed off, and both entities participated. “I realized we were at an impasse, and I was the embodiment of the impasse,” Dr. Zaks said.
Next, when Moderna’s 30,000-person study began enrolling volunteers in July 2020, the subjects weren’t racially diverse enough. Moncef Slaoui, who led Warp Speed’s vaccine efforts, and Dr. Fauci began holding Saturday Zoom calls with Mr. Bancel and other Moderna leaders to “help coax and advise Moderna how to get the percentage of minorities up to a reasonable level,” Dr. Fauci recalled.
Drs. Fauci and Slaoui wanted Moderna to slow down overall enrollment, to give time to find more people of color. Moderna executives resisted at first. “That was very tense,” Dr. Slaoui said. “Voices went up, and emotions were very high.” Moderna ultimately agreed, and the effort worked, but it cost the trial about an extra three weeks. Later, Mr. Bancel called the decision to slow enrollment “one of the hardest decisions I made this year.”
The claim that Fauci cared about racial diversity in the clinical trial is a lie. How do we know this? Later “clinical trials” for Pfizer and Moderna in kids looked at antibodies in the blood, not actual health outcomes, in only about 300 study participants. The number of people of color enrolled in those undersized trials were in the single digits (literally two or three Black participants total) — so those results were not statistically significant. Yet this did not stop authorization. It appears that Fauci’s delay tactics were designed to accomplish a different goal.
Let’s do the math:
Moderna released their preliminary results — claiming 94.5% effectiveness — on November 16, 2020.
The presidential election was less than two weeks earlier — on November 3, 2020.
Trump lost by less than 1% of the vote in 4 key swing states.
Fauci’s demand to slow down enrollment in July 2020 cost Moderna 3 weeks.
If Moderna had released their results 3 weeks earlier — on October 25, 2020, Trump would have scored a major win in the final week of the campaign and won the election.
It does not matter how one feels about Trump or Biden. A massive political win in the week before the election would have convinced enough voters of Trump’s competence and thus pushed Trump’s vote total over the top.
What about Pfizer? They also could have published their preliminary results prior to the election which would have secured Trump’s re-election. According to Loftus, Pfizer “opted out of Operation Warp Speed for fear it would slow the company down.” Pfizer still took $2 billion off of the Trump administration for advance purchase orders. But Scott Gottlieb and Pfizer clearly preferred Biden and so they held their preliminary results until November 9, 2020 — just 6 days after the election. The Biden administration returned the favor by giving Pfizer a blank check and authorizing shots for additional age groups based on the worst “clinical trial” results anyone has ever seen.
The important thing to understand in all of this is that Fauci, the FDA, NIH, and CDC are political functionaries pretending to be scientists. Pandemics, vaccines, and public health are a way for the Democratic Party machine to direct billions of dollars to their base and reward large donors to the party. These companies and their bureaucratic enablers were happy to take money off of Trump. But they knew that they could get an even better deal from Biden.
As you know, the results of this criminal scheme are gruesome. The Covid-19 shots authorized right after the 2020 election have made no discernible impact on the course of the pandemic. Far more people have died of Covid-19 since the introduction of the shots under Biden than during the Trump administration when no Covid-19 shots existed. The Covid-19 shots have negative efficacy and even quadruple-dosed Biden and quadruple-dosed Fauci have contracted Covid-19, twice. These are the deadliest and most toxic shots in the history of the world.
So what started out as a grift turned into mass murder and a crime against humanity.
And now it’s happening again…
II. Pfizer and Moderna move up the release date for reformulated Covid-19 shots in the effort to help Democrats win the midterm elections
On Thursday of last week, the White House and the FDA told their favorite stenographers at the NY Times that Moderna and Pfizer are going to release their reformulated Covid-19 shots, that will completely skip clinical trials, in mid-September.
As readers of my Substack will recall, back on June 28, Pfizer said that the fastest the reformulated shots could be released was October; Moderna said “late October or November” — provided they could skip clinical trials (which of course the FDA granted because they work for Pharma). Did Pfizer and Moderna not understand their own production capabilities? How did Pfizer and Moderna suddenly speed up their production schedule by 6 weeks?
It appears that once again, the public health gatekeepers are doing politics not science. If shots go into bodies in the last two weeks of September, Democrats will claim progress against Covid during October right before the midterm elections on November 8. It’s basically the political win that these same actors denied to Trump (it’s not a public health win, as I will show below).
What’s likely driving this is that Fauci, Pfizer, Moderna, the FDA, CDC, and NIH all want Democrats to retain the House and Senate in order to prevent hearings into their bungling of the Covid-19 response. Of course they also want to keep the Covid-19 vaccine gravy train going as long as possible.
But, you’re surely saying to yourself, we know that these 5th dose reformulated shots are likely to cause catastrophic harms. We’re already seeing a 5% to 15% increase in all-cause mortality across the most heavily vaccinated countries as a result of non-specific effects from these shots. There are 29,790 VAERS reports of death following these shots and this is likely an underestimate by a factor of 41 (so actual death toll = 1,221,390). These reformulated shots are going to use a form of mRNA never tried before and skip clinical trials altogether, so the harms could be even worse. There also seem to be cumulative harms from these shots — the more doses, the more messed up the immune system, the more vulnerable one is to Covid and all sorts of other diseases including cancer.
So how exactly do they plan to get away with this, especially right before an election?
The same way they always get away with it — they own the media. Pfizer and Moderna will rush out press releases claiming that these reformulated shots are a miracle. The CDC’s in-house newsletter, MMWR, will rush out articles and janky studies claiming that these reformulated shots are a miracle. The mainstream media will dutifully report that these reformulated shots are a miracle. Meanwhile, people you know and love — coworkers, friends, neighbors, and family — will be getting injured and killed by these shots. Yet all of the stories in the news will be hosannas about the genius of Tony Fauci, Peter Marks, and the FDA. Billions of dollars of dark money from Pharma will flow into Democratic Congressional campaign coffers. If Democrats can retain the House and Senate they will reward Pfizer and Moderna by blocking any inquiry into the failed Covid-19 response. Win, win, win for Pharma. Everyone else loses.
Which brings me to my last point….
III. Republicans, you have to step up and fight for us or you will lose
Republicans thought that they could take back the House and Senate simply by not being Democrats. Most Republicans did not really fight for us, they just sat back and let Dems destroy themselves. That plan was working until the Supreme Court overturned Roe. Now the Republican advantage in the generic Congressional ballot (‘which party do you prefer’) has evaporated. Pelosi has passed a range of popular bills. Manchin has fallen in line so Biden will likely get some late legislative wins. Gas prices have declined somewhat. And now it appears that Democrats, who were left for dead just weeks ago, will retain the Senate and may retain the House.
IF REPUBLICANS WANT TO WIN THE MIDTERM ELECTIONS THEY HAVE TO MAKE IT ABOUT DEMOCRATS’ FAILED RESPONSE TO COVID!
No more sitting back. No more making warrior mamas do all of the emotional labor for our country. If Republicans want to win they have to make it clear that they will fire, arrest, and prosecute Fauci (and all of his lieutenants) as soon at Republicans take power. Fauci funded the creation of the chimera virus, blocked access to safe and effective treatments, and inflicted deadly toxic vaccines on the entire population. Over 2 million Americans are dead as a direct result of Fauci’s corruption (1 million dead from/with Covid, over 1 million dead from the shots). If Republicans cannot be bothered to sink this two-foot putt then they don’t deserve to win. If Republicans want the votes of the 18 million single-issue medical freedom voters who decide every national election these days — that’s what they have to run on: #ArrestFauci!
How Pfizer Profited From the Pandemic
By Dr. Joseph Mercola | July 18, 2022
According to Kaiser Health News (KHN),1 the COVID-19 pandemic has been a real boon to Pfizer. Not only has it yielded “outsize benefits” in terms of profits, but it has also “given the drugmaker unusual weight in determining U.S. health policy.”
“Based on internal research, the company’s executives have frequently announced the next stage in the fight against the pandemic before government officials have had time to study the issue, annoying many experts in the medical field and leaving some patients unsure whom to trust,” KHN reporter Arthur Allen writes, adding:2
“When last year Bourla suggested that a booster shot would soon be needed, U.S. public health officials later followed, giving the impression that Pfizer was calling the tune.
Some public health experts and scientists worry these decisions were hasty, noting, for example, that although boosters with the mRNA shots produced by Moderna and Pfizer-BioNTech improve antibody protection initially, it generally doesn’t last.
Since January, Bourla has been saying that U.S. adults will probably all need annual booster shots, and senior FDA officials have indicated since April that they agree … The company’s power worries some vaccinologists, who see its growing influence in a realm of medical decision-making traditionally led by independent experts …
When President Biden in September 2021 offered boosters to Americans — not long after [Pfizer CEO Albert] Bourla had recommended them — Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia … wondered, ‘Where’s the evidence you are at risk of serious disease when confronted with COVID if you are vaccinated and under 50?’
Policies on booster recommendations for different groups are complex and shifting, Offit said, but the CDC, rather than Bourla and Pfizer, should be making them. ‘We’re being pushed along,’ he said. ‘The pharmaceutical companies are acting like public health agencies.’”
The fact that a vaccine-pusher like Offit — infamous for claiming a baby can safely tolerate 10,000 vaccines at once3 — is questioning and pushing back against Pfizer’s influence over health policy reveals just how brazen, unethical and potentially dangerous that is.
Massive Profits Made From Useless Products
According to Allen, Pfizer’s revenue in 2021 was $81.3 billion4 — approximately double that of 2020 — and the COVID shot accounted for $36.78 billion5 of that. For comparison, Lipitor, Pfizer’s previous top selling statin, generates roughly $2 billion a year,6 while their strep vaccine, Prevnar 13 rakes in $6 billion a year.7
Its mRNA gene transfer injection against COVID now dominates 70% of the U.S. and European markets, and Paxlovid, Pfizer’s COVID drug, has become a standard treatment choice in hospitals. This, despite researchers finding Paxlovid (molnupiravir) causes severe rebound and supercharges mutations.
In a rational scenario, that finding would have put a stop to its use, but no. In an official health advisory8 to the public, issued May 24, 2022, the U.S. Centers for Disease Control and Prevention first warns that Paxlovid is associated with “recurrence of COVID-19 or ‘COVID-19 rebound,’” and then in the very next sentence stresses in bold print a narrative supporting its use and enriching Pfizer with instructions saying:
“Paxlovid continues to be recommended for early- stage treatment of mild to moderate COVID-19 among persons at high risk for progression to severe disease.”
Allen also notes that, during an investor call, a Pfizer official highlighted reports of Paxlovid’s failure, but spun it into “good news” for investors, as patients may require multiple courses!9 Obviously the objective has long ago shifted from helping humans to raping them for as much profit as possible.
Similarly, while Pfizer’s COVID jab clearly doesn’t prevent infection or spread, and Americans are rejecting the shots in growing numbers — 82.2 million doses had expired and were chucked in the trash as of mid-May 202210 — the U.S. government still went ahead and ordered another 105 million doses at the end of June 2022.
These are intended for a fall booster campaign, at a cost to taxpayers of $3.2 billion.11 The U.S. is actually paying about 50% more for each of these new jab boosters this time around — $30.47 per dose compared to $19.50 per dose paid for the first 100 million doses.
The U.S. government has also promised to purchase another 20 million courses of Paxlovid, at an eye-watering cost of $530 per five-day course. Basically, Pfizer is being financially rewarded for producing products that are useless at best and dangerous at worst, and we’re all paying for it. In case you’re curious, that is another $10.6 billion transferred from U.S. taxpayers to Pfizer.
Future Boosters Won’t Undergo Human Clinical Trials
After you likely thought it couldn’t ever get any worse, KHN also touches on, but doesn’t delve into, the fact that Pfizer suggested they skip human trials as they move forward with jabs that are reformulated for newer variants. If this strikes you as crazy, you’d be right. It’s sheer madness, but the U.S. Food and Drug Administration — a clearly captured agency — has already surreptitiously agreed to this egregious miscarriage of science.
How this wicked scheme, known as the “Future Framework,”12 was adopted by the FDA without formal vote is explained by Toby Rogers, Ph.D. — a political economist whose research focus is on regulatory capture and Big Pharma corruption13 — in the video above. He also explained it in a June 29, 2022, Substack article:14
“Yesterday [June 28], the FDA’s Vaccines and Related Biological Products Advisory Committee approved a bivalent COVID-19 shot with the Wuhan strain and the Omicron variant … Wait, hold up, I thought the FDA was voting on the Future Framework yesterday?
The policy question was whether reformulated COVID-19 shots would be treated as new molecular entities (which they are) in which case they should be subject to formal review or whether reformulated shots would be treated as ‘biologically similar’ to existing Covid-19 shots and be allowed to skip clinical trials altogether.
Apparently the FDA did not have the votes to just pass this as a policy question. If you ask anyone whether reformulated mRNA represents a new molecular entity, well of course it is, so that would require formal regulatory review.
What the FDA did instead was to smuggle the policy question in disguised as a vote about reformulated ‘boosters’ for the fall.
In essence, the FDA just started doing the Future Framework (picking variants willy nilly, skipping clinical trials) and essentially dared the committee members to turn down a booster dose — knowing that all of the VRBPAC members are hand-picked because they’ve never met a vaccine they did not like.
So of course only two people on the committee had the courage to turn down a booster dose — even though it was based on this preposterous process (that was never formally adopted) where there was literally no data at all … By stealth, the FDA replaced a system based on evidence with a system based entirely on belief.”
Countries Held to Ransom
In 2021, secret details of Pfizer’s contracts came to light, showing they are essentially holding countries hostage to nonnegotiable demands for payment in full AND freedom from liability.15
In late February 2021, The Bureau of Investigative Journalism reported16 that Pfizer was demanding countries put up sovereign assets as collateral for expected vaccine injury lawsuits resulting from its COVID-19 jab.
Several countries, including Brazil, Chile, Colombia, the Dominican Republic and Peru, agreed to this demand, putting up bank reserves, military bases and embassy buildings as collateral. In short, theses governments are guaranteeing Pfizer will be compensated for any expenses resulting from injury lawsuits against it, so the company won’t lose a dime if its COVID shot injures people.
Shockingly, these terms are binding even if those injuries are the result of negligent company practices, fraud or malice!
In October that same year, Public Citizen published the secret contracts17,18 between Pfizer and Albania, Brazil, Colombia, Chile, Dominican Republic, the European Commission, Peru, the U.S. and the U.K., further revealing the extent to which these countries handed power over to Pfizer. In almost all scenarios, Pfizer’s interests come first.
For example, government purchasers must acknowledge that the effectiveness and safety of the shots are completely unknown, all while indemnifying Pfizer against any and all financial liability. This is the ultimate corporate maleficence, using their leverage to force the kill shot down these countries’ throats and avoiding any personal responsibility for damages.
Even if Pfizer eventually is convicted of fraud in the U.S. and loses all its liability protection from the COVID jabs because of it, that judgment would not impact these foreign contracts. These countries sold their souls to Pfizer and have absolutely no recourse but to pay even if the shots kill everyone.
The contracts for at least four countries also secure Pfizer’s intellectual property rights even if the company is found to have stolen intellectual property rights of others. In such case, the government purchaser becomes the liable party. As explained by Public Citizen :19
“For example, if another vaccine maker sued Pfizer for patent infringement in Colombia, the contract requires the Colombian government to foot the bill. Pfizer also explicitly says that it does not guarantee that its product does not violate third-party IP, or that it needs additional licenses.
Pfizer takes no responsibility in these contracts for its potential infringement of intellectual property. In a sense, Pfizer has secured an IP waiver for itself. But internationally, Pfizer is fighting similar efforts to waive IP barriers for all manufacturers.”
Equally shocking is that countries are forced to follow through on their vaccine orders even if other drugs or treatments emerge that can prevent, treat or cure COVID-19.20 Is it any wonder, then, that governments around the world have suppressed the use of safe and effective outpatient drugs like hydroxychloroquine and ivermectin?
If these drugs were allowed to be used and could be proven to work, the COVID injections would be completely unnecessary and their emergency use authorization would disappear, yet governments are on the hook for hundreds of millions of doses.
Pfizer Has ‘Habitual Offender’ Track Record
The fact that Pfizer has behaved like a criminal who works out a cover story for a planned murder before committing it is not surprising, considering its history. Pfizer, has been sued in multiple venues over unethical behavior, including unethical drug testing and illegal marketing practices.21
In his 2010 paper,22 “Tough on Crime? Pfizer and the CIHR,” Robert G. Evans, Ph.D., Emeritus Professor at Vancouver School of Economics, described Pfizer as “a ‘habitual offender,’ persistently engaging in illegal and corrupt marketing practices, bribing physicians and suppressing adverse trial results.”
Between 2002 and 2010 alone, Pfizer and its subsidiaries were fined $3 billion in criminal convictions, civil penalties and jury awards. They are recurrent criminal felons. None of these convictions has deterred their nefarious behavior.
In 2011, Pfizer agreed to pay another $14.5 million to settle federal charges of illegal marketing,23 and in 2014 they settled federal charges relating to improper marketing of the kidney transplant drug Rapamune to the tune of $35 million,24 as well as $75 million to settle charges relating to its testing of a new broad spectrum antibiotic on critically ill Nigerian children.
As reported by the Independent 25 at the time, Pfizer sent a team of doctors into Nigeria in the midst of a meningitis epidemic. For two weeks, the team set up right next to a medical station run by Doctors Without Borders and began dispensing the experimental drug, Trovan. Of the 200 children picked, half got the experimental drug and the other half the already licensed antibiotic Rocephin.
Eleven of the children treated by the Pfizer team died, and many others suffered side effects such as brain damage and organ failure. Pfizer denied wrongdoing. According to the company, only five of the children given Trovan died, compared to six who received Rocephin, so their drug was not to blame.
The problem was they never told the parents that their children were being given an experimental drug. What’s more, while Pfizer produced a permission letter from a Nigerian ethics committee, the letter turned out to have been backdated. The ethics committee itself wasn’t set up until a year after the trial had already taken place. Pfizer’s rap sheet also includes bribery, environmental violations, labor and worker safety violations and more.26
Wolves in Sheep’s Clothing
Now, despite Pfizer being one of the least ethical drug companies, we’re told to trust them with our very lives, and the lives of our precious children. They’re going to put out booster shots this fall that have undergone absolutely no testing whatsoever, and we’re to simply throw caution to the wind because Pfizer — which has no liability whatsoever — says so.
In 2014, Pfizer faced a surge of lawsuits that accused it of hiding known side effects of its anticholesterol drug Lipitor.27 They got off scot-free that time, as a federal judge dismissed thousands of cases alleging the drug caused Type 2 diabetes.28,29 But at least they had liability and could be sued.
When it comes to the COVID jabs, injured patients and family members of those killed by it won’t even have the ability to sue for damages, as governments around the world have indemnified them completely, and it looks as though they might not even be liable even if they’re found guilty of fraud. But we will have to see what the courts rule on that one. Still, that any nation would agree to a contract like that is just mindboggling.
Meanwhile, mounting evidence shows the COVID shots destroy immune function over time, and Pfizer’s own trial data reveal deaths and serious adverse events numbering in the tens of thousands.
It’s hard to tell who’s more deserving of punishment — Pfizer or the equally captured federal agencies, the FDA and the CDC, that go along with them and do nothing to protect the lives of the youngest members of our society. Clearly, it’s up to us to protect ourselves and our loved ones, because wolves in sheep’s clothing are ruling the roost — they’re making all the decisions, and captured agencies are simply doing their bidding.
Sources and References
- 1, 2, 4, 9 KHN July 5, 2022
- 3 Science Daily January 10, 2002
- 5 Washington Examiner February 8, 2022
- 6 Axios October 30, 2019
- 7 True Cost of Health Care
- 8 CDC Advisory May 24, 2022
- 10 NBC News June 6, 2022
- 11 Businesswire June 29, 2022
- 12 FDA Briefing Document June 28, 2022
- 13 Brownstone Institute June 22, 2022, Author’s Bio
- 14 uTobian June 29, 2022
- 15 STAT News February 23, 2021
- 16 The Bureau of Investigative Journalism February 23, 2021
- 17, 19 Public Citizen October 19, 2021
- 18 Twitter Zain Rizvi October 19, 2021
- 20 COVID19up.org August 17, 2021 (archived)
- 21 SGT Report January 7, 2021
- 22 Healthcare Policy 2010 May;5(4):16-25
- 23 DOJ October 21, 2011
- 24 Reuters August 6, 2014
- 25 The Independent March 23, 2014
- 26 Corporate Research Project Pfizer
- 27 Reuters August 8, 2014
- 28 Drugwatch Lipitor Lawsuits
- 29 Reuters May 12, 2021
U.S. Orders 2.5 Million More Monkeypox Vaccine Doses, as CDC Looks to Expand Vaccine for Kids
By Suzanne Burdick, Ph.D. | The Defender | July 1, 2022
The Biden administration today said it ordered 2.5 million more doses of Bavarian Nordic’s Jynneos monkeypox vaccine, bringing the total vaccine doses to be delivered in 2022 and 2023 to more than 4 million.
The news followed Tuesday’s announcement of the first phase of the U.S. government’s “national monkey vaccine strategy,” which will expand testing capabilities and make Bavarian Nordic’s Jynneos vaccines readily available to anyone exposed to the virus.
The U.S. Department of Health and Human Services (HHS) said the government’s “enhanced” nationwide strategy “will vaccinate and protect those at-risk of monkeypox,” as well as provide guidance to communities on how to respond to outbreaks.
“We are focused on making sure the public and healthcare providers are aware of the risks posed by monkeypox and that there are steps they can take — through seeking testing, vaccines and treatments — to stay healthy and stop the spread,” said Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC).
As part of the strategy, the CDC and HHS began shipping tests to five major laboratory companies across the country: Aegis Science, Labcorp, Mayo Clinic Laboratories, Quest Diagnostics and Sonic Healthcare.
The government, which for months has been buying more Jynneos doses to add to the national stockpile, is now distributing the vaccine. It’s currently making available 296,000 doses and expects to roll out 750,000 doses over the summer, with an additional 500,000 doses produced and released in the fall — for a total of 1.6 million doses this year.
The Jynneos vaccine is licensed for use in adults and is considered safer than Emergent BioSolutions Inc.’s ACAM2000 smallpox vaccine, which also can be used against monkeypox, the HHS said.
The vaccine will be made available to individuals “with confirmed and presumed monkeypox exposures,” said the HHS.
“This includes those who had close physical contact with someone diagnosed with monkeypox, those who know their sexual partner was diagnosed with monkeypox, and men who have sex with men who have recently had multiple sex partners in a venue where there was known to be monkeypox or in an area where monkeypox is spreading.”
Health officials seeking to expand use of monkeypox vaccine for kids, despite lack of safety data
U.S. health officials also are seeking to expand use of the monkeypox vaccine for children, Bloomberg reported.
The CDC is developing a protocol aimed at allowing use of the Jynneos vaccine in children “should cases in children occur,” Kristen Nordlund, a CDC spokesperson, said in an email to Bloomberg.
“I’m concerned about sustained transmission because it would suggest that the virus is establishing itself, and it could move into high-risk groups, including children, the immunocompromised, and pregnant women,” Tedros Adhanom Ghebreyesus, director-general of the World Health Organization (WHO) said in a Wednesday press briefing.
“We’re starting to see this with several children already infected,” he added.
There have been 350 cases so far of monkeypox in the U.S. — all adults — according to the CDC. The agency confirmed 5,115 cases worldwide.
The WHO confirmed two cases in children in the U.K. and said Wednesday it is following up on reports of cases in children in Spain and France.
No safety trials have been done in children for the Jynneos vaccine as of yet, partly because clinical research involving participants under the age of 18 must pose no more than “minimal risk” to children, which can be difficult for vaccine manufacturers to argue.
Commenting on the CDC’s actions, Dr. Meryl Nass, a member of the Children’s Health Defense scientific advisory committee, told The Defender, “It’s kind of extraordinary that they want to vaccinate everyone in the country before knowing what the safety issues are.”
Nass, an internist and biological warfare epidemiologist, said, “We don’t actually know” if the Jynneos vaccine prevents monkeypox in humans because it was developed as a smallpox vaccine, and prevention studies have been conducted using only animals.
“It is hard to believe that the [U.S. Food and Drug Administration (FDA)] gave this vaccine a license when you read the FDA reviewers’ comments in their own report,” Nass wrote in her June 23 substack newsletter.
“They could not test the vaccine for efficacy against smallpox because there is no smallpox, nor against monkeypox, because the disease is so rare,” Nass wrote. “So the FDA relied on neutralizing antibody titers.”
At the same time, the FDA admitted there is no established correlate of protection, Nass said.
“This means that there is no evidence that the titers represent actual immunity to infection,” Nass wrote. “So FDA relied on animal studies to simply guess the vaccine might be effective in humans.”
According to the FDA, the effectiveness of Jynneos for the prevention of monkeypox is “inferred from the antibody responses in the smallpox clinical study participants and from studies in non-human primates that showed protection of animals vaccinated with Jynneos who were exposed to the monkeypox virus.”
Jynneos, a replication-deficient live Vaccinia virus vaccine, was licensed in the U.S. in 2019, by the FDA for use in individuals 18 and over considered to be at high risk for smallpox or monkeypox.
In 2021, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to recommend Jynneos as a safer alternative to the ACAM2000 vaccine because of ACAM2000’s propensity to cause serious adverse effects, including myocarditis and pericarditis — i.e., inflammation of the heart.
However, Nass noted, Jynneos also was linked to heart inflammation, according to the FDA licensure review of the Jynneos smallpox-monkeypox vaccine which reported:
“Up to 18.4% of subjects in 2 studies developed post-vaccination elevation of troponin [a cardiac muscle enzyme signifying cardiac damage]. However, all of these troponin elevations were asymptomatic and without a clinically associated event or other sign of myopericarditis.”
These higher levels of troponin were not studied further, and the reviewers admitted they did not know if the Jynneos vaccine caused myocarditis, Nass said.
The Jynneos manufacturers said they would conduct an “observational, post-marketing study” in which they would “collect data on cardiac events that occur and are assessed as a routine part of medical care.”
But myocarditis — particularly asymptomatic forms of myocarditis that lack outer signs of the condition — could fly under the radar of the “routine part of medical care,” noted Nass.
The manufacturers would need to test for heightened troponin levels — something that is not typically done in “routine” check-ups.
The authors of a 2015 study reported evidence of heart injury following vaccination in a sample of 1,445 individuals who received a smallpox or trivalent influenza vaccine.
They found that chest pain, shortness of breath and/or palpitations occurred in 10.6% of those who received the smallpox vaccine SPX-vaccinees and 2.6% of those who received the trivalent influenza vaccine within 30 days of immunization.
Additionally, the study authors reported levels more than double the upper limit of troponin — a protein that flags cardiac injury — in 31 of the individuals who received the smallpox vaccine.
“Passive surveillance significantly underestimates the true incidence of myocarditis/pericarditis after smallpox immunization,” they concluded.
The authors added:
“Evidence of subclinical transient cardiac muscle injury post-vaccine immunization is a finding that requires further study to include long-term outcomes surveillance. Active safety surveillance is needed to identify adverse events that are not well understood or previously recognized.”
Suzanne Burdick, Ph.D., is an independent journalist and researcher based in Fairfield, Iowa.
© 2022 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.
CDC Director Violates FDA’s Emergency Use Authorizations and Posts Misinformation about COVID-19 Vaccines

ICAN | June 23, 2022
While Twitter has suspended and permanently blocked numerous individuals for posting so-called “misinformation” concerning COVID-19 vaccines, it has not done so to “health” authorities – those who arguably should be held to an even higher standard – when they blatantly share inaccurate information.
On June 18, 2022, CDC Director Rochelle Walensky posted a tweet with a video of herself discussing the CDC’s recent recommendation of the COVID-19 shots for children under 5. In the video, Dr. Walensky made the following two claims:
- “We now know based on rigorous scientific review that the vaccines available here in the United States can be used safely and effectively in children under 5.”
- “We have taken another important step together on our fight against COVID-19 by making safe and effectivevaccines available for our little ones.”
But as Dr. Walensky should certainly be aware, in issuing Emergency Use Authorizations (EUAs), the FDA has not(under its ridiculously low standards) made a finding that these vaccines are “safe and effective.” Instead, the grant of an EUA means only that the FDA has determined “it is reasonable to believe that [each vaccine] may be effective” and that “it is reasonable to conclude, based on the totality of scientific evidence available, that the known and potential benefits of [each vaccine] outweigh the known and potential risks of the vaccine.”
By claiming – two separate times – that these vaccines are “safe and effective,” Dr. Walensky is misleading the public by suggesting these vaccines have met the legal standard required for licensure.
Worse yet, because her tweet is “descriptive printed matter” that is both advertising and promoting Pfizer’s and Moderna’s vaccines, the tweet itself is in violation of both EUAs issued to these companies because it does not “clearly and conspicuously” contain the required disclaimer that these products have not yet been licensed as safe and effective by the FDA.
ICAN, through its attorneys, has sent Dr. Walensky a formal letter demanding that she immediately remove the misleading tweet and we will keep you posted on the CDC’s response.
CDC Admits It Never Monitored VAERS for COVID Vaccine Safety Signals
By Josh Guetzkow, Ph.D. | The Defender | June 21, 2022
In a stunning development, the Centers for Disease Control and Prevention (CDC) last week admitted — despite assurances to the contrary — the agency never analyzed the Vaccine Adverse Event Reporting System (VAERS) for safety signals for COVID-19 vaccines.
The admission was revealed in response to a Freedom of Information Act (FOIA) request submitted by Children’s Health Defense (CHD).
In September 2021, I published an article in The Defender in which I used the CDC’s published methodology to analyze VAERS for safety signals from COVID-19 vaccines.
The signals were loud and clear, leading me to wonder “why is nobody listening?”
Instead, I should have asked, “Is anybody even looking for them?”
After that article was published, I urged CHD’s legal team to submit a FOIA request to the CDC about its VAERS monitoring activities.
Since CDC officials stated publicly that “COVID-19 vaccine safety monitoring is the most robust in U.S. history,” I had assumed that at the very least, CDC officials were monitoring VAERS using the methods they described in a briefing document posted on the CDC website in January 2021 (and updated in February 2022, with minor changes).
I was wrong.
The lynchpin of their safety monitoring was to mine VAERS data for safety signals by calculating what are known as proportional reporting ratios (PRR’s).
This is a method of comparing the proportion of different types of adverse events reported for a new vaccine to the proportion of those events reported for an older, established vaccine.
If the new vaccine shows a significantly higher reporting rate of a particular adverse event relative to the old one, it counts as a safety signal that should then trigger a more thorough investigation.
The briefing document states, “CDC will perform PRR data mining on a weekly basis or as needed.”

And yet, in the agency’s response to the FOIA request, it wrote that “no PRRs were conducted by CDC. Furthermore, data mining is outside of the agency’s purview.”
The agency suggested contacting the U.S. Food and Drug Administration (FDA), which was supposed to perform a different type of data mining, according to the briefing document.

CDC officials repeatedly claimed they have not seen safety signals in VAERS.

For example, on April 27, 2021, CDC Director Dr. Rochelle Walensky stated the CDC did not see any signals related to heart inflammation.
But a PRR calculation I did using the number of myo/pericarditis reports listed in the first table produced by the CDC obtained via the FOIA request reveals clear and unambiguous safety signals relative to the comparator vaccines mentioned in the briefing document (i.e., flu vaccines, FLUAD and Shingrix).
The table is dated April 2, 2021, almost four weeks before she made those remarks.
In fact, among the 15 adverse events for adults included in that week’s tabulations, PRRs I calculated also show loud-and-clear safety signals for acute myocardial infarction, anaphylaxis, appendicitis, Bell’s palsy, coagulopathy, multisystem inflammatory syndrome in adults (MIS-A), stroke and death.
The actual monitoring the CDC did diverges from the one promised in the briefing document in other ways.
For example, the CDC never created tables of the top 25 adverse events reported in the previous week, tables comparing different vaccine manufacturers, or tables of auto-immune diseases.
And it only began monitoring in early April 2021, even though reports from COVID-19 vaccines had been flooding VAERS since mid-December of the previous year.
To be clear, VAERS is not the only database the CDC uses to monitor COVID-19 vaccine safety.
For example, the CDC sponsored several studies of COVID-19 safety using the Vaccine Safety Datalink (VSD), which is comprised of millions of medical records from HMO’s across several states.
Those studies do not raise many safety concerns. However, they make many questionable methodological choices.
To give one example, a major safety study based on VSD data published in September 2021, in “JAMA,” compares adverse event rates that occur within 1-21 days of vaccination to the rate of occurrence from 22 to 42 days after vaccination.
It makes no comparison between vaccinated and unvaccinated individuals, or before vaccination versus after in the same individuals.
Moreover, the VSD is far from infallible, having failed initially to detect the increase in myocarditis rates.
In contrast, although calculating PRR’s is a blunt pharmacovigilance tool and far from perfect, it nevertheless has the advantage of being straightforward and difficult to manipulate with statistical sleight of hand.
PRRs are one of the oldest, most basic and most well-established tools of pharmacovigilance. The calculations are so straightforward that the CDC automated it several years ago, so it could have been done at the press of a button.
It simply beggars belief that the CDC failed to do this simple calculation. Even now, a paper published by CDC staff in March on the safety of the mRNA COVID-19 vaccines remains purely descriptive with no PRR calculation.
Meanwhile, a study published by a researcher not affiliated with the CDC in February in “Frontiers in Public Health” analyzes VAERS and EudraVigilance data using a method similar to PRRs, revealing clear and concerning safety signals.
And while it is true that VAERS is not the only database the CDC can use to monitor COVID-19 vaccine safety, it is of critical importance because it can reveal signals much faster than any other method — if anybody cares to look for them.
It remains to be seen if the FDA was properly monitoring VAERS. That will be the subject of a future FOIA request.
But even if it was, it doesn’t change the fact that the CDC completely failed in its promise to monitor VAERS for safety signals.
© 2022 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.



